CORE B- PATHOLOGYThe Pathology Core is an important part of the Seattle hematopoietic stem cell transplant program, which issupported by the Adult Leukemia Center (ALC) grant and is located at the Fred Hutchinson CancerResearch Center. The core is a highly integrated group of physicians and laboratory techniciansrepresenting four disciplines. These are pathology, flow cytometry and cell sorting, polymerase chainreaction detection of malignant cell markers, and cytogenetics. The mission of the core is to provide supportnecessary for accomplishing the research goals of the transplant program. Our major focus is the detectionand identification of malignant cells, even when these are present in very small numbers. This information iscritical for successful treatment of patients with cancer. In addition, the core provides very importantinformation about how well the donor cells are populating the bone marrow and producing normal red andwhite blood cells as well as platelets for release into the blood stream. We also have very sensitive methodsfor quickly detecting infection and can evaluate tissue samples for graft-versus-host disease (GVHD) as wellas possible damage from treatment drugs or irradiation. Anatomic pathology uses standard methods inaddition to immunohistochemistry and in situ hybridization on tissue sections to diagnose infection, GVHD,relapse of malignancy or development of second tumors, and the presence and extent of chimerism(thesimultaneous presence of host and donor cells). Molecular cytogenetics uses fluorescence in situhybridization (FISH) to recognize chimerism and tumors. Molecular pathology uses PCR methods to detectminimal residual disease. Multiparameter flow cytometry with sorting provides a highly sensitive method fordetecting small numbers of abnormal cells and separating them for studies carried out by other members ofthe core.Relevance to Public Health:These methods provide key support for virtually all projects and corecomponents of the ALC transplant program. Through these efforts, we are developing improved methods forreturning cancer patients to full health and normal lives. At the same time, we are identifying ways in whichthe body defends itself, and this knowledge can be helpful in attaining the goal of cancer prevention.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA018029-32
Application #
7226433
Study Section
Special Emphasis Panel (ZCA1-RPRB-7 (O5))
Project Start
2006-12-01
Project End
2011-11-30
Budget Start
2007-03-22
Budget End
2008-02-29
Support Year
32
Fiscal Year
2007
Total Cost
$161,956
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Salter, Alexander I; Pont, Margot J; Riddell, Stanley R (2018) Chimeric antigen receptor-modified T cells: CD19 and the road beyond. Blood 131:2621-2629
Lee, Stephanie J; Nguyen, Tam D; Onstad, Lynn et al. (2018) Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:555-562
Bar, Merav; Flowers, Mary E D; Storer, Barry E et al. (2018) Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial. Biol Blood Marrow Transplant 24:308-313
Armenian, Saro H; Yang, Dongyun; Teh, Jennifer Berano et al. (2018) Prediction of cardiovascular disease among hematopoietic cell transplantation survivors. Blood Adv 2:1756-1764
Petersdorf, Effie W; Stevenson, Philip; Malkki, Mari et al. (2018) Patient HLA Germline Variation and Transplant Survivorship. J Clin Oncol 36:2524-2531
Yeung, Cecilia C S; McElhone, Scott; Chen, Xue Yan et al. (2018) Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome. Mod Pathol 31:569-580
Lee, Stephanie J; Onstad, Lynn; Chow, Eric J et al. (2018) Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica 103:1535-1541
McCune, Jeannine S; Storer, Barry; Thomas, Sushma et al. (2018) Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients. Biol Blood Marrow Transplant 24:1802-1807
Deegan, Anthony J; Talebi-Liasi, Faezeh; Song, Shaozhen et al. (2018) Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions. Lasers Surg Med 50:183-193
Leger, Kasey J; Baker, K Scott; Cushing-Haugen, Kara L et al. (2018) Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer 124:1507-1515

Showing the most recent 10 out of 1845 publications